Hydrocephalus and arthrogryposis in an immunocompetent mouse model of ZIKA teratogeny: A developmental study

José Xavier‐Neto(Brazilian Biosciences National Laboratory), Murilo de Carvalho(Brazilian Biosciences National Laboratory), Bruno dos Santos Pascoalino(Brazilian Biosciences National Laboratory), Alisson C. Cardoso(Brazilian Biosciences National Laboratory), Ângela Maria Sousa Costa(Brazilian Biosciences National Laboratory), Ana Helena Macedo Pereira(Brazilian Biosciences National Laboratory), Luana Nunes Santos(Universidade de São Paulo), Ângela Saito(Brazilian Biosciences National Laboratory), Rafael Elias Marques(Brazilian Biosciences National Laboratory), Juliana Helena Costa Smetana(Brazilian Biosciences National Laboratory), Sílvio Roberto Consonni(Brazilian Biosciences National Laboratory), Carla Letícia Bandeira(Universidade de São Paulo), Vivian Vasconcelos Costa(Universidade Federal de Minas Gerais), Marcio C. Bajgelman(Brazilian Biosciences National Laboratory), Paulo Sérgio Lopes de Oliveira(Brazilian Biosciences National Laboratory), Marli Tenório Cordeiro(Universidade Federal de Pernambuco), Laura H. V. G. Gil(Universidade Federal de Pernambuco), Bianca Alves Pauletti(Brazilian Biosciences National Laboratory), Daniela C. Granato(Brazilian Biosciences National Laboratory), Adriana Franco Paes Leme(Brazilian Biosciences National Laboratory), Lúcio H. Freitas-Júnior(Brazilian Biosciences National Laboratory), Carolina Borsoi Moraes(Brazilian Biosciences National Laboratory), Mauro Martins Teixeira(Universidade Federal de Minas Gerais), Estela Bevilacqua(Universidade de São Paulo), Kleber G. Franchini(Brazilian Biosciences National Laboratory)
PLoS neglected tropical diseases
February 23, 2017
Cited by 111Open Access
Full Text

Abstract

The teratogenic mechanisms triggered by ZIKV are still obscure due to the lack of a suitable animal model. Here we present a mouse model of developmental disruption induced by ZIKV hematogenic infection. The model utilizes immunocompetent animals from wild-type FVB/NJ and C57BL/6J strains, providing a better analogy to the human condition than approaches involving immunodeficient, genetically modified animals, or direct ZIKV injection into the brain. When injected via the jugular vein into the blood of pregnant females harboring conceptuses from early gastrulation to organogenesis stages, akin to the human second and fifth week of pregnancy, ZIKV infects maternal tissues, placentas and embryos/fetuses. Early exposure to ZIKV at developmental day 5 (second week in humans) produced complex manifestations of anterior and posterior dysraphia and hydrocephalus, as well as severe malformations and delayed development in 10.5 days post-coitum (dpc) embryos. Exposure to the virus at 7.5-9.5 dpc induces intra-amniotic hemorrhage, widespread edema, and vascular rarefaction, often prominent in the cephalic region. At these stages, most affected embryos/fetuses displayed gross malformations and/or intrauterine growth restriction (IUGR), rather than isolated microcephaly. Disrupted conceptuses failed to achieve normal developmental landmarks and died in utero. Importantly, this is the only model so far to display dysraphia and hydrocephalus, the harbinger of microcephaly in humans, as well as arthrogryposis, a set of abnormal joint postures observed in the human setting. Late exposure to ZIKV at 12.5 dpc failed to produce noticeable malformations. We have thus characterized a developmental window of opportunity for ZIKV-induced teratogenesis encompassing early gastrulation, neurulation and early organogenesis stages. This should not, however, be interpreted as evidence for any safe developmental windows for ZIKV exposure. Late developmental abnormalities correlated with damage to the placenta, particularly to the labyrinthine layer, suggesting that circulatory changes are integral to the altered phenotypes.


Related Papers

No related papers found

Powered by citation graph analysis